This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Biotech Stocks Poised for Breakouts

Cerus

Another stock trading within range of a near-term breakout trade is Cerus (CERS - Get Report), a biomedical products company focused on commercializing the Intercept Blood System to enhance blood safety. This stock is off to a decent start in 2012, with shares up over 20%.

If you look at the chart for Cerus, you'll see that this stock has been uptrending strong since the start of August, with shares trending higher from a low of $3 to its recent high of $3.61 a share. During that uptrend, shares of CERS have been consistently making higher lows and higher highs, which is bullish technical price action. That move has also pushed CERS within range of triggering a near-term breakout trade.

Traders should now look for long-biased trades in CERS if it can manage to break out above some near-term overhead resistance levels at $3.54 to $3.60, and then $3.78 to $3.82 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 286,831 shares. If that breakout triggers soon, then CERS will have a great chance to re-test or possibly take out its next major overhead resistance levels at $4.06 to $4.53 a share.

You could look to buy CERS off weakness and simply use a stop that sits just below its 50-day moving average of $3.26 a share. Or one could buy off strength once CERS starts to take $3.54 to $3.82 with volume, and simply use a stop just below its 200-day moving average of $3.39 a share.
5 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
STEM $0.42 0.00%
CERS $5.25 0.00%
NVAX $11.76 0.00%
SCMP $21.58 0.00%
SGYP $8.68 0.00%

Markets

Chart of I:DJI
DOW 17,550.69 -47.51 -0.27%
S&P 500 2,093.32 -4.72 -0.22%
NASDAQ 5,105.5460 -9.8360 -0.19%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs